$INM

$1.59 +$0.00 (0.0%) Close

$INM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 5.5M shares outstanding

Who owns INM?

By type of holder

Institutions 49.1% Insiders 42.2% Everyone else 8.7%

Concentration Top 10 holders own 71.9%

ADAR1 Capital Management, LLC 14.6% · Vivo Capital, LLC 14.5%

Institutional ownership

49.1%

+43.3 pts vs last qtr

Institutional holders

+11 vs last qtr

Net shares bought

+2.4M

by institutions in Q2 2026

New / sold out

13 / 2

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

ADAR1 Capital Management, LLC NEW +800.0K
Vivo Capital, LLC NEW +798.4K

Biggest sellers in Q2 2026

Sabby Management, LLC −175.3K
Citadel Advisors LLC −20.9K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for InMed Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2026

+992.7%

+230.55% a year

Each share's claim on the business

−90.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $364K

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

445.1%

of institutional shares changed hands

Top 10 managers, median time held

0 quarters

Super Investors

Investment managers reporting INM on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
AC ADAR1 Capital Management, LLC	800.0K	14.56%	NEW	Q2 '26	0.1%
Shares held by quarter Peak holding800.0K (Q2'26) Change over 8 quarters+800.0K Share of the company14.560% ADAR1 Capital Management, LLC's full portfolio →
VC Vivo Capital, LLC	798.4K	14.53%	NEW	Q2 '26	0.1%
Shares held by quarter Peak holding798.4K (Q2'26) Change over 8 quarters+798.4K Share of the company14.530% Vivo Capital, LLC's full portfolio →

ADAR1 Capital Management, LLC

800.0K

% of company

14.56%

Change vs last qtr

NEW

Held since

Q2 '26

Vivo Capital, LLC

798.4K

% of company

14.53%

Change vs last qtr

NEW

Held since

Q2 '26

20 more super investors behind a free account

See every manager holding InMed Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting INM on Form N-PORT; together they hold 0.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
BA Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	$10.1K	6.5K	0.12%	0.00%	June 30, 2026

Blackstone Alternative Multi-Strategy Fund

Blackstone Alternative Investment Funds

Position value

$10.1K

% of company

0.12%

% of the fund

0.00%

As of

June 30, 2026

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
VO Vivo Opportunity, LLC 5%+ holder 13D · 21.7%	718.4K	13.08%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company13.080% Disclosed stake13D · 21.7% View the 13D/G filing →
VO Vivo Opportunity Fund Holdings, L.P. 5%+ holder 13D · 21.7%	718.4K	13.08%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company13.080% Disclosed stake13D · 21.7% View the 13D/G filing →

Vivo Opportunity, LLC

5%+ holder13D · 21.7%

718.4K

% of company

13.08%

Change vs last qtr

—

Held since

—

Vivo Opportunity Fund Holdings, L.P.

5%+ holder13D · 21.7%

718.4K

% of company

13.08%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of InMed Pharmaceuticals Inc.

Comments